OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 141 filers reported holding OCULAR THERAPEUTIX INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $54,071 | -59.6% | 17,220 | -33.7% | 0.00% | – |
Q2 2023 | $133,954 | -11.3% | 25,960 | -9.4% | 0.00% | – |
Q1 2023 | $150,975 | +74.7% | 28,648 | -6.9% | 0.00% | – |
Q4 2022 | $86,438 | -31.4% | 30,761 | +1.1% | 0.00% | – |
Q3 2022 | $126,000 | -4.5% | 30,415 | -7.7% | 0.00% | – |
Q2 2022 | $132,000 | -71.7% | 32,950 | -65.1% | 0.00% | -100.0% |
Q1 2022 | $467,000 | -34.9% | 94,406 | -8.2% | 0.00% | 0.0% |
Q4 2021 | $717,000 | -24.0% | 102,822 | +9.0% | 0.00% | 0.0% |
Q3 2021 | $943,000 | -37.0% | 94,335 | -10.7% | 0.00% | -50.0% |
Q2 2021 | $1,498,000 | -17.0% | 105,633 | -3.9% | 0.00% | 0.0% |
Q1 2021 | $1,804,000 | -16.0% | 109,936 | +6.0% | 0.00% | -33.3% |
Q4 2020 | $2,147,000 | +208.0% | 103,741 | +13.3% | 0.00% | +200.0% |
Q3 2020 | $697,000 | +8.2% | 91,539 | +18.4% | 0.00% | 0.0% |
Q2 2020 | $644,000 | +104.4% | 77,301 | +21.3% | 0.00% | 0.0% |
Q1 2020 | $315,000 | +26.5% | 63,730 | +1.2% | 0.00% | – |
Q4 2019 | $249,000 | +27.0% | 62,978 | -2.5% | 0.00% | – |
Q3 2019 | $196,000 | -23.1% | 64,606 | +11.5% | 0.00% | -100.0% |
Q2 2019 | $255,000 | +18.1% | 57,939 | +6.4% | 0.00% | – |
Q1 2019 | $216,000 | -7.7% | 54,441 | -7.4% | 0.00% | -100.0% |
Q4 2018 | $234,000 | -31.2% | 58,797 | +19.1% | 0.00% | 0.0% |
Q3 2018 | $340,000 | +2.1% | 49,364 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $333,000 | +16.4% | 49,364 | +12.4% | 0.00% | 0.0% |
Q1 2018 | $286,000 | +79.9% | 43,920 | +22.9% | 0.00% | – |
Q4 2017 | $159,000 | -30.6% | 35,739 | -3.5% | 0.00% | -100.0% |
Q3 2017 | $229,000 | -38.1% | 37,039 | -7.3% | 0.00% | 0.0% |
Q2 2017 | $370,000 | -4.6% | 39,939 | -4.5% | 0.00% | 0.0% |
Q1 2017 | $388,000 | +26.0% | 41,839 | +13.6% | 0.00% | 0.0% |
Q4 2016 | $308,000 | +18.0% | 36,839 | -2.9% | 0.00% | 0.0% |
Q3 2016 | $261,000 | +40.3% | 37,939 | +1.1% | 0.00% | – |
Q2 2016 | $186,000 | -40.6% | 37,539 | +15.7% | 0.00% | -100.0% |
Q1 2016 | $313,000 | +19.9% | 32,450 | +16.6% | 0.00% | 0.0% |
Q4 2015 | $261,000 | -32.0% | 27,825 | +1.9% | 0.00% | 0.0% |
Q3 2015 | $384,000 | -23.4% | 27,303 | +14.7% | 0.00% | 0.0% |
Q2 2015 | $501,000 | +13.1% | 23,803 | +125.7% | 0.00% | 0.0% |
Q1 2015 | $443,000 | +77.2% | 10,545 | -0.9% | 0.00% | 0.0% |
Q4 2014 | $250,000 | +57.2% | 10,645 | +0.4% | 0.00% | – |
Q3 2014 | $159,000 | – | 10,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
Covestor Ltd | 60,008 | $316 | 0.28% |
Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |